CompoAtlas

Revilab Anti-AGE (2018.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0001048/2024
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
NPCRIZ Europe, SIA
Manufacturer
slēgta tipa ZAO „GNC PM Farma”/SIA
Form
-
Origin
Latvija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
1 kapsula dienā
Published pack size
kapsulas pa 0,4 g
Published packaging
30 kapsulas

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
Mikroaļģes ekstrakts, kas satur 0,3 mg astaksantīnuplants ; Mikroaļģes ekstrakts, kas satur 0,3 mg astaksantīnu ; Haematococcus pluvialis ; cits ; 8 ; mghaematococcus pluvialisPlant
Rozmarīna ekstraktsplants ; Rozmarīna ekstrakts ; Rosmarinus officinalis ; cits ; 5 ; mgrosmarinus officinalisPlant
TaurīnsotherIngredients ; Taurīns ; 90 ; mgNot recognisedRole not identified
Alfa lipoiskābeotherIngredients ; Alfa lipoiskābe ; 13 ; mgNot recognisedRole not identified
KarnozīnsotherIngredients ; Karnozīns ; 9 ; mgNot recognisedRole not identified
LaktozeotherIngredients ; Laktoze ; - ; mgNot recognisedRole not identified
Mikrokristāliskā celuloze (E460)otherIngredients ; Mikrokristāliskā celuloze (E460) ; - ; mgListed as food additive E 460(i) (EU Union list)Role not identified
Taukskābju kalcija sāļi (E470a)otherIngredients ; Taukskābju kalcija sāļi (E470a) ; - ; mgListed as food additive E 470a (EU Union list)Role not identified
Silīcija dioksīds (551)otherIngredients ; Silīcija dioksīds (551) ; - ; mgNot recognisedRole not identified
ŽelatīnsotherIngredients ; Želatīns ; - ; mgNot recognisedRole not identified
24foodAdditives ; 24Not recognisedRole not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Krievija

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Mikroaļģes ekstrakts, kas satur 0,3 mg astaksantīnu
    Read the warning, when it applies and the studies cited

    Haematococcus pluvialis extract

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Eye strain, Eye fatigue.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 10 January 2025

  • Rozmarīna ekstrakts
    Read the warning, when it applies and the studies cited

    ROSEMARY – ROSMARINUS OFFICINALIS Oral

    Route of administration: Oral (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association’s Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.

    Health Canada monograph dated 29 May 2026

    ROSEMARY - ROSMARINUS OFFICINALIS Topical

    Route of administration: Topical (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association’s Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have large open wounds, skin lesions, feverish conditions, acute inflammation, severe circulatory disorders or hypertension (ESCOP 2003).

    Sources cited by Health Canada (1)
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Barnes et al. 2007; ESCOP 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Health Canada monograph dated 29 May 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Revilab Anti-AGE (2018.)”, https://compoatlas.com/en/supplements/latvia/15406-revilab-anti-age-2018, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line